The Cancer

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Chris Draft mentioned sufferers with lung most cancers and their caregivers can regain management after analysis by displaying up, staying knowledgeable and leaning into advocacy,...

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Vital Information

Facts

Latest Articles

GammaTile Could Cut back Threat of Mind Tumor Recurrence or Dying

Amongst sufferers with operable, newly recognized mind metastases, remedy with GammaTile was related to a higher than 50% discount within the danger...

VCN-01 with Commonplace Care Boosts Survival, Reveals Security in PDAC

Including VCN-01 (zabilugene almadenorepvec) to standard-of-care (SOC) gemcitabine plus Abraxane (nab-paclitaxel) led to improved total survival (OS), progression-free survival (PFS), and length...

Breast Most cancers Survivors Share Recommendation for Newly Identified Sufferers

This Breast Most cancers Consciousness Month, we spoke with two breast most cancers survivors in regards to the steering and encouragement they...

Trodelvy Plus Keytruda Upholds High quality of Life in TNBC

Amongst sufferers with beforehand untreated, PD-L1-positive metastatic triple-negative breast most cancers (mTNBC), therapy with Trodelvy (sacituzumab govitecan) plus Keytruda (pembrolizumab) has been...

Camrelizumab Combo Extends Survival in Metastatic Cervical Most cancers

Camrelizumab together with famitinib produced superior progression-free survival (PFS) outcomes versus platinum-based chemotherapy for the frontline therapy of sufferers with recurrent or...

Hot Topics